These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26176270)

  • 1. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
    Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
    J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy.
    Ma R; Nai J; Zhang J; Li Z; Xu F; Gao C
    Pharm Dev Technol; 2021 Jul; 26(6):634-646. PubMed ID: 33843423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
    Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
    Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ultrasound triggered siRNA delivery.
    Xie X; Yang Y; Lin W; Liu H; Liu H; Yang Y; Chen Y; Fu X; Deng J
    Colloids Surf B Biointerfaces; 2015 Dec; 136():641-50. PubMed ID: 26492155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-responsive nanobubbles contained with peptide-camptothecin conjugates for targeted drug delivery.
    Xie X; Lin W; Liu H; Deng J; Chen Y; Liu H; Fu X; Yang Y
    Drug Deliv; 2016 Oct; 23(8):2756-2764. PubMed ID: 26289216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
    Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
    Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
    Xie X; Yang Y; Yang Y; Zhang H; Li Y; Mei X
    Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
    Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
    Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
    Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
    Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Class of Ultrasound-Triggerable Drug Delivery Systems for the Improved Treatment of Tumors.
    Zhou C; Xie X; Yang H; Zhang S; Li Y; Kuang C; Fu S; Cui L; Liang M; Gao C; Yang Y; Gao C; Yang C
    Mol Pharm; 2019 Jul; 16(7):2956-2965. PubMed ID: 31084010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction.
    Fan X; Wang L; Guo Y; Xiong X; Zhu L; Fang K
    Int J Nanomedicine; 2016; 11():3585-96. PubMed ID: 27536100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Liu Y
    Int J Pharm; 2016 Jun; 506(1-2):158-73. PubMed ID: 27106526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.
    Chen Y; Wu JJ; Huang L
    Mol Ther; 2010 Apr; 18(4):828-34. PubMed ID: 20068551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
    Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
    ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
    Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
    J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-walled carbon nanotube-loaded doxorubicin and Gd-DTPA for targeted drug delivery and magnetic resonance imaging.
    Yan C; Chen C; Hou L; Zhang H; Che Y; Qi Y; Zhang X; Cheng J; Zhang Z
    J Drug Target; 2017 Feb; 25(2):163-171. PubMed ID: 27499100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
    Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
    Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.
    Shi NQ; Li Y; Zhang Y; Li ZQ; Qi XR
    Int J Nanomedicine; 2018; 13():5537-5559. PubMed ID: 30271146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.